Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Theodore L. Underiner is active.

Publication


Featured researches published by Theodore L. Underiner.


Archive | 2007

Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors

Gulzar Ahmed; Adolph C. Bohnstedt; Henry J. Breslin; Jason P. Burke; Matthew A. Curry; James L. Diebold; Bruce D. Dorsey; Benjamin J. Dugan; Daming Feng; Diane E. Gingrich; Tao Guo; Koc-Kan Ho; Keith S. Learn; Joseph G. Lisko; Rong-Qiang Liu; Eugen F. Mesaros; Karen L. Milkiewicz; Gregory R. Ott; Jonathan Parrish; Jay Theroff; Tho V. Thieu; Rabindranath Tripathy; Theodore L. Underiner; Jason C. Wagner; Linda Weinberg; Gregory J. Wells; Ming You; Craig A. Zificsak


Archive | 2000

Cyclic substituted fused pyrrolocarbazoles and isoindolones

Robert L. Hudkins; Dandu R Reddy; Jasbir Singh; Rabindranath Tripathy; Theodore L. Underiner


Archive | 2004

Novel fused pyrrolocarbazoles

Robert L. Hudkins; Allison L. Zulli; Dandu R Reddy; Diane E. Gingrich; Ming Tao; Nadine C. Becknell; James L. Diebold; Theodore L. Underiner


Archive | 2011

PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS

Henry J. Breslin; Sankar Chatterjee; James L. Diebold; Bruce D. Dorsey; Derek Dunn; Diane E. Gingrich; Greg A. Hostetler; Robert L. Hudkins; Rachael Hunter; Kurt A. Josef; Joseph G. Lisko; Eugen F. Mesaros; Karen L. Milkiewicz; Gregory R. Ott; Babu G. Sundar; Jay Theroff; Tho V. Thieu; Rabindranath Tripathy; Theodore L. Underiner; Linda Weinberg; Gregory J. Wells; Craig A. Zificsak


Archive | 2004

Fused pyrrolocarbazoles and methods for the preparation thereof

Robert L. Hudkins; Dandu R Reddy; Ming Tao; Theodore L. Underiner; Allison L. Zulli


Archive | 2009

Pyrrolotriazine as ALK inhibitor and JAK2

Henry J. Breslin; Sankar Chatterjee; James L. Diebold; Bruce D. Dorsey; Derek Dunn; Diane E. Gingrich; Greg A. Hostetler; Robert L. Hudkins; Rachael Hunter; Kurt A. Josef; Joseph G. Lisko; Eugen F. Mesaros; Karen L. Milkiewicz; Gregory R. Ott; Babu G. Sundar; Jay Theroff; Tho V. Thieu; Rabindranath Tripathy; Theodore L. Underiner; Linda Weinberg; Gregory J. Wells; Craig A. Zificsak


Archive | 2007

NUEVOS PIRROLOCARBAZOLES FUSIONADOS

Nadine C. Becknell; James L. Diebold; Diane E. Gingrich; Robert L. Hudkins; Dandu R Reddy; Ming Tao; Theodore L. Underiner; Allison L. Zulli


Archive | 2007

Pyrido [2, 3-b] pyrazine and [1, 8] -naphthyridine derivatives as alk and c-met inhibitors

Bruce D. Dorsey; Karen L. Milkiewicz; Douglas A. Pippin; Jay P. Theroff; Theodore L. Underiner; Linda Weinberg; Craig A. Zificsak


Archive | 2007

Dérives bicycliques fusionnes de 2,4-diaminopyrimidine utilises comme inhibiteurs de alk et c-met

Gulzar Ahmed; Adolph C. Bohnstedt; Henry J. Breslin; Jason P. Burke; Matthew A. Curry; James L. Diebold; Bruce D. Dorsey; Benjamin J. Dugan; Daming Feng; Diane E. Gingrich; Tao Guo; Koc-Kan Ho; Keith S. Learn; Joseph G. Lisko; Rong-Qiang Liu; Eugen F. Mesaros; Karen L. Milkiewicz; Gregory R. Ott; Jonathan Parrish; Jay Theroff; Tho V. Thieu; Rabindranath Tripathy; Theodore L. Underiner; Jason C. Wagner; Linda Weinberg; Gregory J. Wells; Ming You; Craig A. Zificsak


Molecular Cancer Therapeutics | 2007

CEP-11981: Identification of an orally bioavailable TIE-2/VEGF-R2 inhibitor with broad kinase inhibitory activity

Theodore L. Underiner; Lisa D. Aimone; Mark S. Albom; Thelma S. Angeles; Mark A. Ator; Ed Bacon; Nadine C. Becknell; Robert L. Hudkins; Marty Jacobs; Keith S. Learn; John P. Mallamo; Sherri Meyer; Chung Ho Park; Dan Pauletti; Dandu R Reddy; Damaris Rolon-Steele; Bruce Ruggeri; Chrysanthe Spais; Ming Tao; Jason C. Wagner; Linda Weinberg; Shi Yang; Allison L. Zulli; Gary McCort

Collaboration


Dive into the Theodore L. Underiner's collaboration.

Researchain Logo
Decentralizing Knowledge